These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37011005)

  • 1. EIF4A3 Acts on the PI3K-AKT-ERK1/2-P70S6K Pathway through FLOT1 to Influence the Development of Lung Adenocarcinoma.
    Yu W; Liang J; Fang T; Jiang J; Zhao R; Li R; Han J; Tian H
    Mol Cancer Res; 2023 Jul; 21(7):713-725. PubMed ID: 37011005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmacytoma variant translocation 1 stabilized by EIF4A3 promoted malignant biological behaviors of lung adenocarcinoma by generating circular RNA LMNB2.
    Qiu M; Chen M; Lan Z; Liu B; Xie J; Li X
    Bioengineered; 2022 Apr; 13(4):10123-10140. PubMed ID: 35435126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway.
    Liang J; Li H; Han J; Jiang J; Wang J; Li Y; Feng Z; Zhao R; Sun Z; Lv B; Tian H
    Cell Death Dis; 2020 Aug; 11(8):614. PubMed ID: 32792503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway.
    Zhang S; Leng T; Zhang Q; Zhao Q; Nie X; Yang L
    Biomed Pharmacother; 2018 Jun; 102():302-308. PubMed ID: 29571014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FHL2 promotes the aggressiveness of lung adenocarcinoma by inhibiting autophagy via activation of the PI3K/AKT/mTOR pathway.
    Wang S; Liu B; Su Y; Wang N; Dong P; Xu X; Huang L; Li S; Gu J; Qiu Y; Deng J; Lin Z; Zhou Y
    Thorac Cancer; 2024 Mar; 15(8):630-641. PubMed ID: 38323374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PLEK2 activates the PI3K/AKT signaling pathway to drive lung adenocarcinoma progression by upregulating SPC25.
    Zhang W; Yu L; Xu C; Tang T; Cao J; Chen L; Pang X; Ren W
    Cell Biol Int; 2024 Sep; 48(9):1285-1300. PubMed ID: 38894536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FLOT1 promotes tumor development, induces epithelial-mesenchymal transition, and modulates the cell cycle by regulating the Erk/Akt signaling pathway in lung adenocarcinoma.
    Zhang L; Mao Y; Mao Q; Fan W; Xu L; Chen Y; Xu L; Wang J
    Thorac Cancer; 2019 Apr; 10(4):909-917. PubMed ID: 30838797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
    Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic zinc finger protein ZNF687 accelerates lung adenocarcinoma cell proliferation and tumor progression by activating the PI3K/AKT signaling pathway.
    Li M; Liu Z; Hou Z; Wang X; Shi H; Li Y; Xiao X; Tang Z; Yang J; Luo Y; Zhang M; Chen M
    Thorac Cancer; 2023 May; 14(14):1223-1238. PubMed ID: 36944484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLITRK6 promotes the progression of lung adenocarcinoma by regulating PI3K/AKT/mTOR signaling and Warburg effect.
    Yu F; Zhao X; Li M; Meng M
    Apoptosis; 2023 Aug; 28(7-8):1216-1225. PubMed ID: 37219677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SLC39A5 promotes lung adenocarcinoma cell proliferation by activating PI3K/AKT signaling.
    Liu Z; Hu Z; Cai X; Liu S
    Pathol Res Pract; 2021 Aug; 224():153541. PubMed ID: 34252710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FAM83B promotes the invasion of primary lung adenocarcinoma via PI3K/AKT/NF-κB pathway.
    Zhang J; Wang J; Yue K; Li P; Shen W; Qiao X; Wang Y; Wu X
    BMC Pulm Med; 2023 Jan; 23(1):32. PubMed ID: 36690987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF2BP3 aggravates lung adenocarcinoma progression by modulation of PI3K/AKT signaling pathway.
    Chen X; Zhu X; Shen X; Liu Y; Fu W; Wang B
    Immunopharmacol Immunotoxicol; 2023 Jun; 45(3):370-377. PubMed ID: 36972188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA LINC00511 promotes COL1A1-mediated proliferation and metastasis by sponging miR-126-5p/miR-218-5p in lung adenocarcinoma.
    Wang Y; Mei X; Song W; Wang C; Qiu X
    BMC Pulm Med; 2022 Jul; 22(1):272. PubMed ID: 35842617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer/testis antigen LDHC promotes proliferation and metastasis by activating the PI3K/Akt/GSK-3β-signaling pathway and the in lung adenocarcinoma.
    Chen L; Wu Q; Xu X; Yang C; You J; Chen F; Zeng Y
    Exp Cell Res; 2021 Jan; 398(2):112414. PubMed ID: 33301764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Junctional adhesion molecule-like protein as a novel target for kaempferol to ameliorate lung adenocarcinoma.
    Wu Q; Wang YB; Che XW; Wang H; Wang W
    J Integr Med; 2023 May; 21(3):268-276. PubMed ID: 37069006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMC2 knockdown inhibits malignant progression of lung adenocarcinoma by upregulating BTG2 expression.
    He Y; Wang Y; Luo Z; Zhang X; Bai H; Wang J
    Cell Signal; 2024 Aug; 120():111216. PubMed ID: 38729325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA (let-7b-5p)-targeted DARS2 regulates lung adenocarcinoma growth by PI3K/AKT signaling pathway.
    Xu Y; Chen X
    Oncol Res; 2024; 32(3):517-528. PubMed ID: 38361754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Centromere protein N promotes lung adenocarcinoma progression by activating PI3K/AKT signaling pathway.
    Zheng Y; You H; Duan J; Chen B; Wu C; Chen P; Wang M
    Genes Genomics; 2022 Sep; 44(9):1039-1049. PubMed ID: 35150399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.